Artelo Biosciences ARTL Cash Flow Statement (2014-2025)

NASDAQ ARTL
$0.71 -0.01 (-1.39%)
At close: Aug 20, 2026 · 4:00 PM EDT
1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement May2014 Aug2014 Nov2014 Feb2015 May2015 Aug2015 Nov2015 Feb2016 May2016 Aug2016 Nov2016 Feb2017 May2017 Aug2017 Nov2017 Feb2018 May2018 Aug2018 Nov2018 Feb2019 May2019 Aug2019 Nov2019 Feb2020 May2020 Aug2020 Nov2020 Feb2021 May2021 Aug2021 Nov2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Operating Activities
Net Income (Quarter)
-2.02M-2.33M-3.78M-2.55M-1.92M-2.49M-2.40M-3.47M-2.30M-1.81M-2.65M-3.24M-2.61M-2.53M-1.20M-9.49M-2.38M-3.67M-3.19M-2.76M
Depreciation and Depletion (Quarter)
62.0061.00
Share-based Compensation (Quarter)
0.34M0.57M0.62M0.62M0.61M0.61M0.35M0.23M0.22M0.22M0.21M0.20M0.21M0.20M0.19M0.15M0.43M0.37M
Gains from Investment Securities (Quarter)
0.02M0.01M
Asset Writedowns and Impairment (Quarter)
0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M
Cash from Operations (Quarter)
-1.50M-1.93M-2.05M-1.97M-1.70M-2.29M-2.19M-1.62M-1.80M-2.60M-2.94M-2.06M-0.78M-2.57M-1.60M-0.51M-3.50M-2.91M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
Depreciation & Amortization (CF) (Quarter)
62.0061.00
Change in Working Capital
Change in Account Payables (Quarter)
0.01M0.02M0.01M-0.02M0.03M0.03M-0.04M0.00M-0.02M0.05M-0.04M-0.01M0.03M-0.04M0.00M0.01M0.31M
Change in Accured Expenses (Quarter)
0.11M0.13M-0.16M-0.38M-0.02M0.55M-0.21M-0.19M0.33M0.37M-0.62M0.26M0.37M0.45M0.80M2.25M-0.91M-0.83M
Other Working Capital Changes (Quarter)
-0.09M-0.01M-0.21M-0.09M0.59M-0.26M-0.07M-0.01M-0.04M-0.48M0.06M-0.01M-0.05M-0.05M-0.02M
Investing Activities
Capital Expenditures (Quarter)
Change in Acquisitions & Divestments (Quarter)
1.88M2.70M4.72M4.25M-11.15M6.49M2.75M2.75M3.69M1.75M1.75M4.25M0.50M
Cash from Investing Activities (Quarter)
-0.51M-8.88M0.26M3.98M-3.08M1.80M2.20M0.40M-1.83M2.74M1.27M1.75M4.25M0.50M-0.25M0.19M
Financing Activities
Other financing activities (Quarter)
5.29M0.57M0.06M
Cash from Financing Activities (Quarter)
5.32M18.26M-0.13M0.13M0.54M0.03M0.06M0.06M1.82M3.44M1.61M
Change in Capital Stock
Net Equity Issued and Repurchased (Quarter)
1.01M18.26M0.54M0.03M0.06M0.06M1.08M1.76M1.76M
Additional items
Exchange Rate Effect (Quarter)
0.01M-0.04M-0.02M-0.11M-0.21M0.12M0.01M0.03M0.02M-0.00M-0.00M-0.00M0.00M-0.01M0.01M0.02M-0.04M-0.00M
Change in Cash (Quarter)
3.32M7.42M-1.81M1.77M-4.99M-0.25M0.03M-1.20M-3.08M0.18M-1.62M-0.31M3.48M-2.02M-1.59M1.32M-0.35M-1.12M
Free Cash Flow (Quarter)
-1.50M-1.93M-2.05M-1.97M-1.70M-2.29M-2.19M-1.62M-1.80M-2.60M-2.94M-2.06M-0.78M-2.57M-1.60M-0.51M-3.50M-2.91M
Net Cash Flow (Quarter)
3.31M7.46M-1.80M1.89M-4.78M-0.36M0.01M-1.22M-3.10M0.18M-1.62M-0.31M3.47M-2.01M-1.60M1.30M-0.30M-1.12M